BHVN Competitors & Alternatives
Compare Biohaven Ltd. with similar stocks in the same industry
Biotechnology
BHVN
Main Stock$11.28
Tradestie Score
61
Market Cap
$1.57B
Analyst Upside
+92.4%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$34.26
|
$1.84B | - | 60 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$28.96
|
$1.81B | - | 59 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.24
|
$1.78B | - | 57 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$18.19
|
$1.78B | - | 58 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$16.35
|
$1.74B | - | 62 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$31.27
|
$1.68B | - | 59 | Compare |
|
MNKD
Mannkind Corporation
|
$3.66
|
$1.65B | - | 64 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$34.83
|
$1.63B | - | 56 | Compare |
|
VCEL
Vericel Corporation
|
$37.46
|
$1.56B | 89.7 | 61 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$82.07
|
$1.55B | - | 54 | Compare |
More BHVN Analysis
Data updated: Jun 15, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry